[绒促性素与胎盘肿瘤]
[Choriogonadotrophic hormone and placental tumors].
作者信息
Amiel J L, Droz J P, Ben Ayed F
出版信息
Ann Endocrinol (Paris). 1984;45(4-5):231-3.
PMID:6535444
Abstract
The radioimmunological dosage of choriogonadotrophic hormone is the actual basis for the choice of patients to be treated, to recognize the poor prognosis cases, to adjust the treatment in drugs, doses and durations, to detect the relapses. The clinicien must obey the biologist who is always right.
摘要
绒毛膜促性腺激素的放射免疫剂量是选择治疗患者、识别预后不良病例、调整药物治疗、剂量和疗程以及检测复发情况的实际依据。临床医生必须听从生物学家的意见，因为生物学家永远是正确的。
相似文献
1
[Choriogonadotrophic hormone and placental tumors].[绒促性素与胎盘肿瘤]
Ann Endocrinol (Paris). 1984;45(4-5):231-3.
2
[Treatment of the choriocarcinoma].
Gynecol Prat. 1967;18(6):555-68.
3
Hydatidiform mole. A follow-up regimen for identification of invasive mole and choriocarcinoma and for selection of patients for treatment.
Am J Obstet Gynecol. 1968 Jun 15;101(4):557-63.
4
Trophoblastic disease.滋养细胞疾病
Int J Gynaecol Obstet. 2012 Oct;119 Suppl 2:S130-6. doi: 10.1016/S0020-7292(12)60026-5.
5
[Current treatment of trophoblastic tumors].
Gynaecologia. 1969;167(5):399-404.
6
[Hydatidiform mole, trophoblastic tumor/choriocarcinoma].[葡萄胎、滋养细胞肿瘤/绒毛膜癌]
Gynakol Geburtshilfliche Rundsch. 1992;32 Suppl 1:125-6. doi: 10.1159/000271970.
7
Current approaches to diagnosis and treatment of gestational trophoblastic disease.妊娠滋养细胞疾病的当前诊断与治疗方法。
Curr Opin Obstet Gynecol. 1993 Feb;5(1):84-91.
8
Gestational trophoblastic tumours. Two. Choriocarcinoma.妊娠滋养细胞肿瘤。二、绒毛膜癌。
Nurs Times. 1984;80(7):42-4.
9
[Clinical and therapeutic trends in the treatment of hydatidiform mole].[葡萄胎治疗的临床与治疗趋势]
Ann Ostet Ginecol Med Perinat. 1976 Nov-Dec;97(6):362-73.
10
[Management of gestational trophoblastic disease].[妊娠滋养细胞疾病的管理]
Gynecol Obstet Fertil. 2010 Mar;38(3):193-8. doi: 10.1016/j.gyobfe.2010.01.011. Epub 2010 Feb 26.
Zotero 插件